Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 35433301000001111 | Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 53189501000001110 | Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) infusion 500ml polyethylene bottles 1 bottle | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Is pack of | Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles | false | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has active ingredient | Monobasic potassium phosphate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has active ingredient | Disodium acid phosphate | false | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has manufactured dose form | Solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has manufactured dose form | Conventional release solution for injection | false | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has VMP | Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has specific active ingredient | Monobasic potassium phosphate | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has specific active ingredient | Disodium acid phosphate | true | Inferred relationship | Existential restriction modifier | ||
| Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Has dispensed dose form | Infusion | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Polyfusor NA phosphates solution for injection 500ml bottles (Fresenius Kabi Ltd) 1 bottle | Is a | True | Sodium phosphate dibasic 2.875g/500ml / Monopotassium phosphate 647.5mg/500ml (potassium 9.5mmol/500ml) solution for injection 500ml polyethylene bottles 1 bottle | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR